NEW YORK (Reuters Health) - Studies evaluating cholesterol-lowering drugs might find more muscle problems if they did a better job of defining and asking about muscle pain, suggests a new review.
A meta-analysis encompassing data from 23 randomized clinical trials and more than 150,000 participants has concluded muscle pain or weakness is not a common side effect from statin drug therapy. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback